Allspring Global Investments Holdings LLC trimmed its position in The Clorox Company (NYSE:CLX – Free Report) by 6.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 136,184 shares of the company’s stock after selling 9,245 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Clorox were worth $22,039,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in CLX. Brooklyn Investment Group grew its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC increased its position in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC purchased a new stake in Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial acquired a new position in Clorox in the third quarter valued at about $49,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Ratings Changes
CLX has been the topic of a number of research analyst reports. Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. DA Davidson cut their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $158.21.
Clorox Stock Performance
Shares of CLX stock opened at $147.91 on Friday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The company has a market cap of $18.31 billion, a P/E ratio of 40.41, a PEG ratio of 2.52 and a beta of 0.42. The firm has a fifty day moving average price of $159.17 and a 200 day moving average price of $159.23.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company posted $2.16 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th were issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. The ex-dividend date of this dividend was Wednesday, January 29th. Clorox’s payout ratio is 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- How to Invest in Biotech Stocks
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What is the Nikkei 225 index?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.